Researchers uncover how neurons deliver RNA where it is needed
Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Fast-acting actin explains the survival of cancer cells
Phase 2 data for chronic inducible urticaria
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
Positive results from phase 1 Huntington’s disease trial
Potential for drug targeting BDCA2 and TACI
CCHF in the crosshairs
Kalexo Bio formed to advance siRNA therapy for cardiovascular disorders
First liquid ambient temperature stable qPCR master mixes